Biotech · Public company · San Diego, CA, US
Erasca, Inc.
Ticker ERAS · SEC CIK 0001761918
Track this companyFree. Adds Erasca, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials105 recruiting or active
Pipeline programs25From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline25
- DacarbazinePhase 3 · Advanced or Metastatic NRAS-mutant MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- NaporafenibPhase 3 · Advanced or Metastatic NRAS-mutant MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- TemozolomidePhase 3 · Advanced or Metastatic NRAS-mutant MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- TrametinibPhase 3 · Advanced or Metastatic NRAS-mutant MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- CetuximabPhase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- EncorafenibPhase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- ERAS-007Phase 2 · Advanced or Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- ERAS-007Phase 2 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- ERAS-007Phase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- ERAS-601Phase 2 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- ERAS-601Phase 2 · Advanced or Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- GilteritinibPhase 2 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- PalbociclibPhase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- CetuximabPhase 1 · Advanced or Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- ERAS-0015Phase 1 · Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- ERAS-0015 in combinationPhase 1 · Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- ERAS-007Phase 1 · Advanced Non-squamous Non-small-cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- ERAS-4001Phase 1 · Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- ERAS-4001 in combinationPhase 1 · Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- ERAS-601Phase 1 · Advanced Non-squamous Non-small-cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- NaporafenibPhase 1 · Advanced or Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- OsimertinibPhase 1 · Advanced Non-squamous Non-small-cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 1 · Advanced or Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- SotorasibPhase 1 · Advanced Non-squamous Non-small-cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- TrametinibPhase 1 · Advanced or Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials10
- A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.PHASE1 · RECRUITING · started Aug 6, 2025ClinicalTrials.gov NCT07021898 · fetched Nov 12, 2026
- A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid TumorsPHASE1 · RECRUITING · started Jun 5, 2025ClinicalTrials.gov NCT06983743 · fetched Nov 12, 2026
- A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)PHASE3 · ACTIVE_NOT_RECRUITING · started Apr 29, 2024ClinicalTrials.gov NCT06346067 · fetched Nov 12, 2026
- A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X MutationsPHASE1 · ACTIVE_NOT_RECRUITING · started Aug 17, 2023ClinicalTrials.gov NCT05907304 · fetched Nov 12, 2026
- A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Hematologic MalignanciesPHASE1_PHASE2 · WITHDRAWN · started Mar 15, 2022ClinicalTrials.gov NCT05279859 · fetched Nov 12, 2026
- A Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)PHASE1 · ACTIVE_NOT_RECRUITING · started Feb 25, 2022ClinicalTrials.gov NCT05222802 · fetched Nov 12, 2026
- A Study of ERAS-007 in Patients With Advanced Gastrointestinal MalignanciesPHASE1_PHASE2 · COMPLETED · started Sep 20, 2021ClinicalTrials.gov NCT05039177 · fetched Nov 12, 2026
- A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLCPHASE1 · COMPLETED · started Sep 2, 2021ClinicalTrials.gov NCT04959981 · fetched Nov 12, 2026
- A Study of ERAS-007 as Monotherapy or in Combination With ERAS-601 in Patients With Advanced or Metastatic Solid TumorsPHASE1_PHASE2 · COMPLETED · started May 7, 2021ClinicalTrials.gov NCT04866134 · fetched Nov 12, 2026
- A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid TumorsPHASE1 · COMPLETED · started Dec 15, 2020ClinicalTrials.gov NCT04670679 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Oct 16, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 24, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 14, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 1, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 27, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 27, 2026 · fetched Nov 12, 2026